Shijiazhuang Yiling Pharmaceutical Co.,Ltd.’s Net Profit Rose 15.5% in First Three Quarters of 2022
Listen to the full version

Shijiazhuang Yiling Pharmaceutical Co.,Ltd. (石家庄以岭药业股份有限公司) (002603.SZ) reported a net profit of 1.4 billion yuan in the first three quarters of 2022, up 15.5% year-on-year.
Meanwhile, the company posted 7.9 billion yuan in revenue, down 2% year-on-year.
At the end of the reporting period, it had 14.9 billion yuan in total assets and 4.9 billion yuan in total liabilities, with a liability-to-asset ratio of 33.1%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR